Healthcare & LifeSciences

Our lifesciences expertise extends across the product life cycle, from drug development to commercialization.

Among other matters, we advise on M&A, co-development and licensing transactions, manufacturing, marketing & distribution agreements, and clinical development & clinical trials.​

Our Lifesciences and Healthcare lawyers have previously worked in large pharmaceutical companies with global operations. They understand the commercial and regulatory nuances of this highly specialized industry and are skilled at navigating its complexities. This allows us to deliver not just legal but commercially sound and strategically superior advice.

In addition to supporting on specific contracts, deals, or financings, we also offer a ‘general counsel service’ where we assist your business or legal teams with your ongoing legal, contractual, and compliance requirements. Our in-depth, core-level understanding of the healthcare industry and pragmatic, get-it-done approach makes dealing with us as effortless as leveraging your internal resources.

Our Expertise

Our Services

  • M&A: whether acquisitions or dispositions.
  • Joint Ventures and other strategic collaborations.
  • FDI, Private Equity/Venture Capital investment or other forms of financing.
  • In-licensing and Out-licensing.
  • Biologics and biosimilars: supply chain, licensing and collaborations.
  • Supply and distribution deals with purchasers or distributors.
  • Contract Development and Manufacturing.
  • Contract Research.
  • Drug development and Co-Development.
  • Clinical Trials.
  • Technology Transfer or Joint Development.
  • ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Warehousing/leases/logistics.
  • Marketing, promotion and HCP contracts.
  • Advise on regulatory issues and disputes.

Representative Experience

a. Biologics & Biosimilars experience

  • High value out licensing transactions with Mylan and Nichi-Iko for Etanercept (Enbrel).
  • In-licensing for Bevacizumab (Avastin) with Reliance Life Science.
  • Advised on biosimilars joint venture and contract manufacturing agreements with Yoshindo (of Japan), and related disputes.
  • Drug development, technology transfer, contract manufacturing and financing agreements for various biosimilars.

b. Licensing and Supply Chain experience

  • High value in-licensing transactions with Novartis, Astellas, Merck, Vifor Pharma, Boehringer-Ingelheim and Eli Lilly, for various innovator drugs.
  • Contract and toll manufacturing agreements with e.g. Shilpa Medicare, Gland Pharma and Astral Pharma.
  • Purchase/procurement agreements for Active Pharmaceutical Ingredients, Key Starting Materials and Intermediates.
  • Supply and distribution deals with leading Asian distributors DKSH, Zuellig and Mega.

c. Digital Health

  • Advising an Indian healthtech and fitness company on a range of regulatory and legal issues related to medical device regulations, intellectual property, data protection and privacy, including collection, use, and storage of personal health data.
  • Advising a healthtech company on regulatory compliance, commercialization, and market entry strategy in various jurisdictions including the US, UAE, Singapore, UK, and EU, together with local counsel.

d. Drug Development

  • Advising an innovative neuroscience company on legal and contractual issues in connection with their multi-site clinical trials across multiple jurisdictions including US, UK and EU, together with local counsel.
  • Advising an innovative neuroscience company on a range of commercial contracts including licensing agreements, clinical trial agreements, contract development and manufacturing agreements, supply agreements, master services agreements, material testing agreements, and data protection agreements.
  • Advising a UAE-based healthcare-focused fund on a global drug co-development and licensing transaction, including overseeing due diligence, legal and tax structuring, and transaction documentation, together with local counsel and tax advisors.

Insights/News